Search for content, post, videos
Advertisement

Kvantify secures EUR 10 million seed round

The round is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and the private investment company 2degrees.

The investment will accelerate the development of Kvantify’s solutions that aim to leverage quantum computing to address complex problems in drug discovery and beyond. It will also boost the further development of quantum algorithms for chemical simulation, expanding their applicability across various industries.

Read more: Quantum computing – Solving the most complex life science issues

Advertisement

“On behalf of the founding team, we are incredibly excited about the completion of our EUR 10 million seed round, which marks a significant milestone for Kvantify. This funding not only validates our vision of leveraging quantum computing to revolutionize the life sciences industry but also provides us with the resources and strategic partnerships needed to accelerate our development and growth. With the support of new and existing investors, we are well-positioned to continue to bring groundbreaking solutions to market,” says Hans Henrik Knudsen, CEO of Kvantify.

Quantum computing

The seed round is led by Danish VC Dreamcraft, together with Lundbeckfonden BioCapital and the private investment company 2degrees. Other investors include international sector-focused tech investor Redstone VC, Danish lead quantum VC 2xN as well as EIFO. This is Lundbeckfonden BioCapital’s first investment outside the therapeutics space.

“With our investment in Kvantify, we are broadening our footprint in and commitment to further strengthening the Danish life science ecosystem. Quantum computing can deliver accuracy and derisking to the early stages of drug development to a level not possible with classical computers, thereby enabling faster speed to market. We are therefore excited about this opportunity and look forward to working with the Kvantify team to bridge quantum computing and drug development to the future benefit of patients,” says Jacob Falck Hansen, Partner at Lundbeckfonden BioCapital.

Read more: International center for medical quantum sensing to be established in Copenhagen

Photo of the founders of Kvantify: Hans Henrik Knudsen, CEO, Nikolaj Zinner and Allan Grønlund

Advertisement